Analyst Activity – Needham & Company LLC Raises Its Price Target On NASDAQ:CNMD – CONMED (NASDAQ:CNMD) to $73.00

ME Staff
-
0

Analyst Ratings For NASDAQ:CNMD – CONMED (NASDAQ:CNMD)

Today, Needham & Company LLC raised its price target on NASDAQ:CNMD – CONMED (NASDAQ:CNMD) to $73.00 per share.

Some recent analyst ratings include

  • 11/3/2017-KeyCorp Reiterated Rating of Hold.
  • 11/3/2017-Piper Jaffray Reiterated Rating of Hold.
  • 4/27/2017-Ladenburg Thalmann was Downgraded by analysts at Ladenburg Thalmann from a “Buy ” rating to a ” Neutral” rating. They now have a $48.00 price target on the stock, up previously from $50.00 .
  • 11/23/2016-Leerink Swann Reiterated Rating of Hold .

Dividend information for NASDAQ:CNMD – CONMED (NASDAQ:CNMD)

NASDAQ:CNMD – CONMED (NASDAQ:CNMD) pays an annual dividend of $0.80 with a yield of 1.22%.

Dividend History for NASDAQ:CNMD – CONMED (NASDAQ:CNMD)

  • On 2/28/2018 NASDAQ:CNMD – CONMED announced a quarterly dividend of $0.20 1.31169044105591% with an ex dividend date of 3/14/2018 which will be payable on 4/5/2018.
  • On 11/28/2017 NASDAQ:CNMD – CONMED announced a quarterly dividend of $0.20 1.48% with an ex dividend date of 12/14/2017 which will be payable on 1/5/2018.
  • On 8/29/2017 NASDAQ:CNMD – CONMED announced a quarterly dividend of $0.20 1.65% with an ex dividend date of 9/14/2017 which will be payable on 10/5/2017.
  • On 5/24/2017 NASDAQ:CNMD – CONMED announced a quarterly dividend of $0.20 1.6% with an ex dividend date of 6/13/2017 which will be payable on 7/5/2017.
  • On 2/28/2017 NASDAQ:CNMD – CONMED announced a quarterly dividend of $0.20 1.92% with an ex dividend date of 3/13/2017 which will be payable on 4/5/2017.
  • On 11/21/2016 NASDAQ:CNMD – CONMED announced a quarterly dividend of $0.20 1.77% with an ex dividend date of 12/13/2016 which will be payable on 1/5/2017.
  • On 8/25/2016 NASDAQ:CNMD – CONMED announced a quarterly dividend of $0.20 1.99% with an ex dividend date of 9/13/2016 which will be payable on 10/5/2016.

Recent Insider Trading Activity For NASDAQ:CNMD – CONMED (NASDAQ:CNMD)
NASDAQ:CNMD – CONMED (NASDAQ:CNMD) has insider ownership of 2.62% and institutional ownership of 99.35%.

  • On 3/9/2018 Terence M Berge, VP, sold 3,868 with an average share price of $62.45 per share and the total transaction amounting to $241,556.60.
  • On 3/1/2018 Luke A Pomilio, CFO, sold 19,620 with an average share price of $60.19 per share and the total transaction amounting to $1,180,927.80.
  • On 2/12/2018 Luke A. Pomilio, CFO, sold 1,962 with an average share price of $60.25 per share and the total transaction amounting to $118,210.50.
  • On 2/1/2018 Jo Ann Golden, Director, sold 3,000 with an average share price of $63.90 per share and the total transaction amounting to $191,700.00.
  • On 2/1/2018 Luke A. Pomilio, CFO, sold 18,023 with an average share price of $63.38 per share and the total transaction amounting to $1,142,297.74.
  • On 1/3/2018 Charles Farkas, Director, bought 158 with an average share price of $50.61 per share and the total transaction amounting to $7,996.38.
  • On 11/9/2017 Luke A Pomilio, EVP, sold 29,363 with an average share price of $50.70 per share and the total transaction amounting to $1,488,704.10.

Recent Trading Activity for NASDAQ:CNMD – CONMED (NASDAQ:CNMD)
Shares of NASDAQ:CNMD – CONMED closed the previous trading session at 65.46 up +2.35 3.72% with 67.38999938964844 shares trading hands.